ACAD
34.83
+0.38
+1.10%
AEMD
3.35
-0.4
-10.67%
APRI
2.25
-0.04
-1.75%
ARNA
1.46
+0.01
+0.69%
ATEC
2.19
+0.12
+5.80%
CNAT
4.82
+0.23
+5.01%
CRXM
0.2
0.00
0.00%
CYTX
1.65
+0.01
+0.61%
DXCM
82.62
+6.54
+8.60%
GNMK
13.4
+0.26
+1.98%
HALO
13.53
+0.07
+0.52%
ILMN
170.58
+2.89
+1.72%
INNV
0.11
0.00
+4.08%
INO
6.05
+0.1
+1.68%
ISCO
1.78
+0.13
+7.88%
ISIS
57.56
0.00
0.00%
LGND
104.78
+0.99
+0.95%
LPTN
2.93
-0.08
-2.66%
MBVX
2.27
-0.24
-9.56%
MEIP
1.54
-0.03
-1.91%
MNOV
5.87
+0.06
+1.03%
MRTX
5.15
+0.05
+0.98%
MSTX
0.114
+0.007
+6.542%
NBIX
41.98
+0.48
+1.16%
NUVA
74.85
+0.56
+0.75%
ONCS
1.27
+0.02
+1.60%
ONVO
3.03
+0.02
+0.66%
OREX
3.98
-0.02
-0.50%
OTIC
12.85
-0.25
-1.91%
QDEL
21.84
+0.17
+0.76%
RCPT
231.96
0.00
0.00%
RGLS
1.4
+0.15
+12.00%
RMD
71.57
+0.26
+0.36%
SPHS
2.87
+0.29
+11.24%
SRNE
4.1
-0.1
-2.38%
TROV
1
-0.15
-13.04%
VICL
2.15
+0.02
+0.94%
VOLC
18
0.00
0.00%
ZGNX
10.45
+0.05
+0.48%
ACAD
34.83
+0.38
+1.10%
AEMD
3.35
-0.4
-10.67%
APRI
2.25
-0.04
-1.75%
ARNA
1.46
+0.01
+0.69%
ATEC
2.19
+0.12
+5.80%
CNAT
4.82
+0.23
+5.01%
CRXM
0.2
0.00
0.00%
CYTX
1.65
+0.01
+0.61%
DXCM
82.62
+6.54
+8.60%
GNMK
13.4
+0.26
+1.98%
HALO
13.53
+0.07
+0.52%
ILMN
170.58
+2.89
+1.72%
INNV
0.11
0.00
+4.08%
INO
6.05
+0.1
+1.68%
ISCO
1.78
+0.13
+7.88%
ISIS
57.56
0.00
0.00%
LGND
104.78
+0.99
+0.95%
LPTN
2.93
-0.08
-2.66%
MBVX
2.27
-0.24
-9.56%
MEIP
1.54
-0.03
-1.91%
MNOV
5.87
+0.06
+1.03%
MRTX
5.15
+0.05
+0.98%
MSTX
0.114
+0.007
+6.542%
NBIX
41.98
+0.48
+1.16%
NUVA
74.85
+0.56
+0.75%
ONCS
1.27
+0.02
+1.60%
ONVO
3.03
+0.02
+0.66%
OREX
3.98
-0.02
-0.50%
OTIC
12.85
-0.25
-1.91%
QDEL
21.84
+0.17
+0.76%
RCPT
231.96
0.00
0.00%
RGLS
1.4
+0.15
+12.00%
RMD
71.57
+0.26
+0.36%
SPHS
2.87
+0.29
+11.24%
SRNE
4.1
-0.1
-2.38%
TROV
1
-0.15
-13.04%
VICL
2.15
+0.02
+0.94%
VOLC
18
0.00
0.00%
ZGNX
10.45
+0.05
+0.48%
Home » Archive by Category

Syndication

Nucleotide Manufacturing Senior Process Engineer – Illumina, Inc. – San Diego, CA

March 23, 2017 – 4:04 pm

Work experience in the biotech or semiconductor industries is desirable. This individual will lead teams that provide technical leadership to optimize, improve…From Illumina, Inc. – Fri, 24 Mar 2017 00:04:14 GMT – View all San Diego jobs

Senior Scientist, Cell Biology – Celgene – San Diego, CA

March 23, 2017 – 3:53 pm

The Structural and Chemical Biology Department is seeking an experienced and highly motivated cell biologist to help drive our drug discovery efforts….From Celgene – Thu, 23 Mar 2017 23:53:36 GMT – View all San Diego jobs

Scientist, Toxicology/Preclinical Safety Assessment – Vertex Pharmaceuticals – San Diego, CA

March 23, 2017 – 3:30 pm

Vertex Pharmaceuticals uses cutting edge science and technologies to transformative therapies for the treatment of the most serious diseases with unmetFrom Vertex Pharmaceuticals – Thu, 23 Mar 2017 23:30:22 GMT – View all San Diego jobs

UX Designer – Pathway Genomics – San Diego, CA

March 23, 2017 – 3:26 pm

Minimum 3 years related experience in Biotechnology or regulated industry experience desire. Based in San Diego, Pathway Genomics CLIA and CAP accredited…From Indeed – Thu, 23 Mar 2017 23:26:58 GMT – View all San Diego jobs

NOW HIRING 8 SALES REPS – $40,000-$85,000 + Benefits + Growth (San Diego)

March 23, 2017 – 2:06 pm

17-year-old Digital Marketing agency is seeking to hire new inside sales consultants. The company provides Social Media, Web Marketing, SEO and other online marketing solutions to businesses throughout the USA.
We especially are seeking to hire energ […

Head of Real Estate Development – BioMed Realty – San Diego, CA

March 23, 2017 – 12:13 pm

BioMed Realty delivers optimal real estate solutions for biotechnology, pharmaceutical, and medical device companies, scientific research institutions,…From BioMed Realty – Thu, 23 Mar 2017 20:13:17 GMT – View all San Diego jobs

Topsalysin Data from Successful Phase 2a Localized Prostate Cancer Study to be Presented at the 32nd European Association of Urology Congress

March 23, 2017 – 12:05 pm

Poster selected as one of the best in a poster session during the 32nd Annual EAU Congress

SAN DIEGO and VANCOUVER, British Columbia, March 23, 2017 /PRNewswire/ — Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced that data from its successful Phase 2a study of topsalysin, which evaluated the drug as a focal treatment for localized prostate cancer, will be presented as a poster on March 26, 2017 at the 32nd Annual European Association of Urology in London, UK. The poster has been selected by conference organizers as one of the best posters at the congress.

Abstract No. 758: “Intra-prostatic injection of PRX302 to focally ablate clinically significant prostate cancer: An open label, phase 2a study”
Presenting Author:  Dr. Yaalini Shanmugabavan, Division of Surgery and Interventional Sciences, University College London, London, UK
Poster Session:  Poster Session 57 – Prostate cancer: Is the future focal?
Time:  March 26, 2017 from 3:45 pm5:15 pm GMT

The abstract related to the poster can be accessed through the European Association of Urology Congress website at http://eau17.uroweb.org/.

About Sophiris
Sophiris Bio Inc. is a biopharmaceutical company developing topsalysin (PRX302) for the treatment of patients with urological diseases. Topsalysin is in Phase 2 clinical development for the focal treatment of localized prostate cancer as well as Phase 3 clinical development for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH). Topsalysin is a highly potent ablative agent that is selective and targeted in that it is only activated by enzymatically active PSA which is found in high concentrations in the transition zone of the prostate and in and around prostate tumor cells.  More than 400 patients have received treatment with topsalysin, which continues to appear to be safe and well tolerated. For more information, please visit www.sophirisbio.com.

Company Contact:
Peter Slover
Chief Financial Officer
(858) 777-1760

Corporate Communications and Media Contact:
Jason Spark
Canale Communications
(619) 849-6005
jason@canalecomm.com

 

SOURCE Sophiris Bio Inc.

Research Animal Technician – California Medical Innovations Institute – San Diego, CA

March 23, 2017 – 11:41 am

Provides guidance and direction for less experienced staff. Ability to document clearly and appropriately. Applies emergency medical knowledge as necessary with…From Indeed – Thu, 23 Mar 2017 19:41:43 GMT – View all San Diego jobs

Research Analyst (UTC)

March 23, 2017 – 8:27 am

Research Analyst — Informa | Pharma Intelligence, San Diego, CA Informa Pharma Intelligence is seeking a Research Analyst to join its San Diego Biomedtracker team. Informa’s Pharma Intelligence is the trusted partner of all of the top 50 global phar […

Manager, Upstream Biologics – Ajinomoto Althea, Inc. – San Diego, CA

March 23, 2017 – 6:43 am

Is a fully integrated contract development and manufacturing organization providing clinical drug process development and manufacturing services to global…From BioSpace.com – Thu, 23 Mar 2017 14:43:39 GMT – View all San Diego jobs